Background. Respiratory syncytial virus (RSV) is the major cause of severe lower respiratory tract infection in infants and young children. Recently, RSV has also been recognized as a serious health risk in elderly individuals, but the pathogenesis of RSV infection in elderly individuals remains unknown.
Respiratory syncytial virus (RSV) is the most important cause of serious lower respiratory tract infection in infants and young children [1, 2] . Although a strong antibody response is invoked by RSV, immunity is shortlived and reinfection by RSV is common throughout life. Recently, RSV has also been recognized as a serious health risk in elderly individuals [3] [4] [5] . The incidence of RSV disease in the institutionalized elderly is 5%-10% per year, with pneumonia and death occurring in 10%-20% and 2%-5% of those infected, respectively [4] . As a cause of excess morbidity and mortality in individuals 165 years of age, RSV is second only to influenza [6, 7] .
It is not clear why elderly individuals are predisposed to a more-severe RSV infection. Antibody immunity does not appear to be responsible for excess RSV disease developing with age, because the antibody response to RSV mounted by elderly individuals is comparable to that of young adults [8, 9] . Aging is associated with considerable decreases in CD4 + and CD8 + T cell-mediated responses [10] . Cellular immune responses play an important role in controlling RSV infection [11] . In humans, defects in cellular immune responses, such as in immunosuppressed and transplant patients, are associated with prolonged RSV shedding that often leads to severe pneumonia and death [12] [13] [14] [15] .
Cytokines play an important role in regulating the immune response to natural RSV infection, to reinfection, and during RSV vaccine-enhanced disease [11, [16] [17] [18] [19] . There are variable reports on the effect that age has on cytokine responses. Although some investigators have demonstrated lower interferon (IFN)-g and higher interleukin (IL)-4 and IL-10 responses in elderly individuals than in young individuals [20] , others have indicated an increase in both Th1-type and Th2-type responses in elderly individuals [21] . Although an age-specific decline in CD8 + T cell responses to influenza infection has been reported in humans [22, 23] , there are no conclusive reports of age-specific decline in cellmediated immunity to RSV. One study has reported decreased RSV-induced production of IFN-g by whole peripheral blood mononuclear cells in elderly individuals [24] . Another report has indicated that the frequency of RSV-specific CD8 + T cells secreting IFN-g was comparable between young and elderly individuals and that age was rather associated with the reduced ratio of IL-10:IFN-g among elderly individuals [25] .
Our laboratory has previously demonstrated that age has a dramatic effect on RSV replication in the upper and lower respiratory tracts of young and aged cotton rats [26] , the preferred small animal model for clinically relevant research on RSV prophylaxis [27] [28] [29] . Because of the importance of proper cytokine balance for RSV pathogenesis, we have now compared pulmonary cytokine response to acute RSV infection in young and aged cotton rats. The modulation of the cytokine response by treatments that target viral replication and/or immunoinflammatory response induced by RSV is also assessed with respect to age.
MATERIALS AND METHODS

Cotton rats.
Inbred Sigmodon hispidus cotton rats were obtained from a colony at Virion Systems, Inc. Cotton rats were housed in large polycarbonate rat cages with a bedding of paper-mill by-products (Care Fresh; Absorption) and were fed a standard diet of rodent chow and water. The colony was monitored for antibodies to paramyxoviruses, and no such antibodies were found. No murine pathogens in the viral, mycoplasmal, helminth, protozoan, or arthropod groups were isolated or otherwise detected in the colony. Aged cotton rats used for these experiments were 19 months old (average age, months), and young cotton rats were !2 months 12.4 ‫ע‬ 0.2 old (average age, months). The average life expec-1.7 ‫ע‬ 0.1 tancy of colony-bred S. hispidus is ∼16 months. All studies were conducted under applicable laws and guidelines and after obtaining approval from the Virion Systems, Inc., Institutional Animal Care and Use Committee.
Viruses and viral assays. The prototype Long strain of RSV was obtained from American Type Culture Collection. Virus was propagated in HEp-2 cells and serially plaque purified to reduce defective-interfering particles [30] . A single pool of virus containing pfu/mL was used. Viral titers in the lungs 7 3.7 ϫ 10 of infected cotton rats were determined by plaque assay [31] and expressed as geometric values for all cotton mean ‫ע‬ SE rats in a group.
Drugs. The humanized monoclonal antibody palivizumab (Synagis), directed against the F-protein of RSV, was provided by MedImmune. Triamcinolone acetonide suspension (Kenalog-40; Bristol-Myers Squibb; later referred to as "triamcinolone") was obtained from Henry Schein.
Experimental design. Young and aged cotton rats were inoculated intranasally under isoflurane anesthesia with 100 mL of RSV suspension (10 6 pfu/cotton rat). On days 4, 6, and 8 after infection, 4-5 cotton rats from each age group were killed by CO 2 inhalation, and lungs were trisected for viral titers and histological and RNA analyses.
For antiviral and anti-inflammatory treatments of RSV infection, cotton rats were inoculated intranasally under isoflurane anesthesia with 100 mL of RSV suspension (10 6 pfu/cotton rat). Three days later, cotton rats were given a single intramuscular injection of palivizumab (15 mg/kg) and/or an intramuscular injection of triamcinolone (4 mg/kg). Cotton rats receiving triamcinolone continued to get injections of that drug on 2 additional days. The effective doses of palivizumab and triamcinolone for treatment of aged cotton rats were chosen on the basis of earlier experiments with young cotton rats [32] . On day 6 after infection, all cotton rats were killed, and the lungs were trisected for viral titers and histological and RNA analyses. The number of cotton rats per treatment group was 4-10 in the aged cotton rat category and 5 in the young cotton rat category. Two independent experiments of identical design were performed.
Histological analysis. Lungs were prepared for histological analysis as described elsewhere [33] . Each lung section was scored for 4 independent parameters of pulmonary inflammation, including peribronchiolitis, perivasculitis, alveolitis, and interstitial pneumonitis [33] . The maximum possible value for each lesion was 100. Lesion scores were expressed as arithmetic values for all cotton rats in a group. Student's mean ‫ע‬ SE t test was used to evaluate differences among groups.
Reverse-transcriptase polymerase chain reaction (PCR) analysis of pulmonary cytokine expression. Total RNA was extracted from homogenized lung tissue by use of the RNeasy purification kit (Qiagen). One microgram of total RNA was used to prepare cDNA using oligo dT primers and Super Script II RT (Invitrogen). IFN-g, IL-10, IL-6, monocyte chemoattractant protein (MCP)-1, growth-regulated oncogene (GRO), and IL-4 were PCR amplified using the primers and conditions described elsewhere [19, 34, 35] . b-actin was included as a housekeeping gene to control for differences in cDNA between the cotton rats. Amplified products were quantified using the Southern blot procedure with chemiluminescent detection as described elsewhere [34] . The signal for each gene was normalized to the b-actin level in the lung. Cytokine levels were expressed as the geometric values for all cotton rats mean ‫ע‬ SE Downloaded from https://academic.oup.com/jid/article-abstract/195/4/511/2191807 by guest on 02 April 2020 in a group. Differences among groups were evaluated by Student's t test of summary data.
RESULTS
Pulmonary cytokine expression in the aged and young cotton rats during acute RSV infection. Infection of aged cotton rats
with RSV resulted in efficient viral replication in the lungs with the maximum viral load levels comparable between the aged and young cotton rats ( figure 1A ). High (∼10 5 pfu/g) viral titers were detected in the lungs of aged cotton rats on days 4 and 6 after infection, and virus was cleared from the lungs by day 8. Young cotton rats showed RSV presence in the lungs only on day 4 and cleared the virus by day 6. These observations were consistent with previous work from our laboratory that showed that older cotton rats (16 months old and up to 15-16 months old) had delayed virus clearance from the lungs, compared with that of younger cotton rats (4-6 weeks old) [26] . No apparent differences in the intensity of pulmonary lesions were noted among different age groups in this or earlier work (data not shown).
We assessed expression of cytokines IFN-g, IL-4, IL-10, and IL-6 and chemokines MCP-1 and GRO in the lungs of aged and young cotton rats infected with RSV. Th1-type cytokine IFN-g, Th2-type cytokines IL-4 and IL-10, and proinflammatory cytokine IL-6 were chosen for analysis because of their importance for RSV pathogenesis, as well as because of the reported Th1/Th2-type and pro-/anti-inflammatory cytokine dysregulation that might occur with age [16, 17, 20, 21, [36] [37] [38] . MCP-1 and neutrophil chemoattractant GRO (analogue of human IL-8) were included in the study because of the central role that these chemokines and the cells they attract/ activate play in initiating innate immune response to RSV and in clearing the virus [18, 37, 39] .
All the cytokines analyzed, with the exception of IL-4 (data not shown), were up-regulated by RSV infection in both young and aged cotton rats (figure 1B). Basal levels of mRNA expression of all these mediators in uninfected aged cotton rats were low and comparable to the basal levels of these mRNAs found in young uninfected cotton rats. RSV infection of aged cotton rats resulted in elevated expression of mRNA for all these cytokines on days 4 and 6 after infection and persisted for some cytokines (e.g., IFN-g and IL-10) through day 8. Young cotton rats up-regulated IFN-g, IL-10, and MCP-1 transcripts on both days 4 and 6 after infection, whereas increased levels of IL-6 and GRO mRNA were more limited to day 4. Overall, expression of all cytokines in young cotton rats appeared to peak on day 4, and expression of the majority of cytokines analyzed in aged cotton rat reached peak on day 6. mRNA expression levels of the majority of the cytokines in the lungs of young cotton rats 6 days after RSV infection was lower than that in the lungs of aged cotton rats, most likely reflecting effective clearance of the virus from the lungs of young cotton rats by this time. The maximum level of expression of all cytokines was comparable between young and aged cotton rats, with the only exception being GRO mRNA, which was significantly higher in aged cotton rats ( ). P p .04 Antiviral and/or anti-inflammatory treatment of aged cotton rats. To correlate the expression of lung cytokines with the cytopathic and immunomodulatory components of RSV pathogenesis, we infected cotton rats with RSV and treated cotton rats with palivizumab and/or triamcinolone. Previous work has demonstrated that combined administration of the antiviral antibody palivizumab and the anti-inflammatory corticosteroid triamcinolone reduces viral load and at the same time down-regulates the inflammatory response to RSV in young cotton rats [32] . Administered individually, antiviral antibodies diminish pulmonary RSV replication in young cotton rats, without reducing inflammation, whereas corticosteroids reduce pulmonary inflammation while delaying viral clearance. These treatments appeared to be an attractive tool to investigate the contribution of various aspects of RSV pathogenesis to associated cytokine expression. However, it was not clear whether antiviral and/or anti-inflammatory therapies would be as effective in aged cotton rats as they were in young cotton rats.
To address this question, aged cotton rats were infected with RSV and treated with palivizumab and/or triamcinolone. Effectiveness of antiviral and/or anti-inflammatory therapies was assessed 6 days after RSV-infection, the time of peak histological changes in the lungs. In the absence of any treatment, aged cotton rats contained 110 4 pfu/g RSV in their lungs on day 6 after infection, whereas young cotton rats had cleared the virus by that time ( figure 2A ). Palivizumab treatment reduced pulmonary viral titers among aged cotton rats to undetectable levels. Although antiviral treatment reduced viral replication, anti-inflammatory treatment with triamcinolone resulted in an increase of viral titers in the lungs of both aged and young cotton rats. Combined antiviral and anti-inflammatory treatment of RSV infection suppressed RSV replication in the lungs of aged cotton rats. Combined antiviral and anti-inflammatory intervention appeared to have lesser effect on RSV replication than antiviral antibody alone. A similar trend was noted among young cotton rats.
To evaluate effectiveness of various treatments in combating lung inflammation induced by RSV infection of aged cotton rats, pulmonary inflammation was compared between aged and young cotton rats infected with RSV on day 6 after infection. In the absence of any treatment, the extent of pulmonary inflammation was comparable between aged and young cotton rats ( figure 2B ). Palivizumab treatment of either aged or young cotton rats had little effect on pulmonary inflammation of infected cotton rats, whereas pulmonary pathology was dramatically reduced among both age groups after triamcinolone ad- ministration and after combined treatment with palivizumab and triamcinolone. Overall, these results indicate that antiviral and/or anti-inflammatory therapies are as effective in controlling viral replication and/or pulmonary inflammation among aged cotton rats as they are among young rats.
We noted increased mortality in the RSV-infected cotton rats treated with a combination of palivizumab and triamcinolone: 10 of 26 aged cotton rats and 2 of 15 young cotton rats died after combination treatment in several experiments. The majority of deaths (9/10 among aged and 2/2 among young cotton rats) occurred between days 5 and 6 of the experiment, after the third and the last inoculation of triamcinolone. The increased mortality was not due to RSV infection, because uninfected but treated cotton rats had similar mortality: 7 of 20 control aged cotton rats not infected with RSV, but otherwise treated in the same manner with palivizumab and triamcinolone, died by day 6 of the experiment. No mortality was noted among young RSV-infected cotton rats treated with palivizumab or triamcinolone individually, although a moderate increase in mortality was seen among aged RSV-infected cotton rats treated with triamcinolone alone (4/21 cotton rats died after the third dose of corticosteroid). Necropsies performed did not reveal a cause of death. Cotton rats that died were excluded from further analysis.
Modulation of cytokine expression by antiviral and/or antiinflammatory treatment.
Cytokine expression was analyzed in the lungs of RSV-infected aged and young cotton rats on day 6 after infection after various types of treatments of RSV disease. As shown in figure 3 and in the previous experiment ( figure 1B) , RSV infection resulted in strong up-regulation of IFN-g, IL-10, IL-6, MCP-1, and GRO mRNA in the lungs of aged cotton rats.
Modulation of RSV disease by anti-inflammatory and/or antiviral compounds produced characteristic changes in the pattern of pulmonary cytokine expression that can be grouped as follows. mRNA levels of IFN-g, IL-10, and MCP-1 in aged cotton rats reduced dramatically after anti-inflammatory treatment, whereas antiviral treatment had a much lesser effect on expression of these cytokines ( figure 3) . Combined antiviral and anti-inflammatory treatment reduced the pulmonary presence of these cytokines' transcripts to basal level. IL-6 expression was reduced after antiviral treatment, whereas an increase in the mRNA expression of this cytokine was visible after antiinflammatory treatment. Combined antiviral and anti-inflammatory treatment had little effect on pulmonary IL-6 mRNA levels. GRO pulmonary transcripts were lowered by all kinds of treatment given to RSV-infected aged cotton rats.
Young cotton rats responded to various treatments of RSV disease with the same basic trends in cytokine expression changes as did aged cotton rats. For example, levels of IFN-g, IL-10, and MCP-1 mRNA were reduced more by anti-inflam- Control rats were infected with RSV, but received no treatment (Ϫ). All cotton rats were killed 6 days after infection, and the lungs were collected for viral titrations. Results are the values of 2 independent experiments. B, Histological analysis of lungs in aged and young RSV-average ‫ע‬ SE infected cotton rats after various types of treatment for RSV infection. Aged and young cotton rats were infected and treated as in panel A. All cotton rats were killed on day 6 after infection, and lungs were inflated for histological analysis. Histological changes were scored in each of 4 individual categories: peribronchiolitis, perivasculitis, interstitial inflammation, and alveolitis. Results are values of individual scores. mean ‫ע‬ SE matory than by antiviral treatment, IL-6 mRNA levels were increased after anti-inflammatory treatment, and RSV-infected cotton rats given a combined antiviral and anti-inflammatory treatment had an overall lower pulmonary cytokine mRNA expression than did RSV-infected untreated cotton rats. The effect that treatments have on pulmonary expression of GRO mRNA in young cotton rats 6 days after RSV infection was difficult to evaluate considering the low level of its expression at this time point.
DISCUSSION
The fact that RSV represents a serious health risk for elderly individuals is becoming increasingly recognized [5] . Yet, little is known about the pathogenesis of RSV infection in elderly individuals. It is likely that virus-induced damage and host response to RSV infection both contribute to the development of RSV disease in elderly individuals, just as these 2 deciding factors orchestrate RSV infection in younger humans and cotton rats, but this hypothesis has not been tested. In the present study, we have used treatment approaches that diminish viral replication (antiviral antibodies) and pulmonary inflammation (corticosteroids) in young RSV-infected cotton rats to evaluate the contribution of virus-induced and inflammatory processes to the development of disease in aged cotton rats. Our results indicate that treatment of RSV infection with antiviral antibodies and corticosteroids (either individually or in combination) in aged cotton rats has a similar effect on RSV infection to that reported for young cotton rats [32, 40] . Thus, cytopathic and immunoinflammatory effects appear to contribute to the development of RSV disease not only in young but also in aged cotton rats. An increased mortality was noted among aged cotton rats treated with triamcinolone alone or with a combination of triamcinolone and palivizumab, which may be related to a lower tolerance of high doses of corticosteroids by aged cotton rats. Some mortality was also noted in young cotton rats undergoing combination treatment, for reasons currently unknown. Some fundamental differences in age-related immune response to viral pathogens must predispose human elderly to more severe RSV disease. In the case of influenza viruses, a decline in cellular immunity was found to make elderly indi- Figure 3 . Changes in cytokine expression in the lungs of aged and young cotton rats after various types of treatment for respiratory syncytial virus (RSV) infection. Cotton rats were infected with RSV and treated with antiviral compound palivizumab (aV), with anti-inflammatory compound triamcinolone acetonide (aI), or with a combination of the 2 (a[V+I]). One control group (Ϫ) of cotton rats in each age category was infected with RSV but received no treatment. An additional control group of aged cotton rats was included to determine background expression of those cytokines in unmanipulated aged cotton rats. All cotton rats were killed 6 days after infection, and cytokine mRNA expression in the lungs was analyzed by reverse-transcription polymerase chain reaction and normalized to the b-actin mRNA level. Results are the values of 2 independent experiments. average ‫ע‬ SE * , comparing mRNA expression in RSV-infected treated group with P ! .05 mRNA expression in RSV-infected untreated cotton rats within the same age category. GRO, growth-regulated oncogene; IFN, interferon; IL, interleukin; MCP, monocyte chemoattractant protein.
viduals more susceptible to severe infections [22, 41] . Aging was also proposed to be associated with decreased cytotoxic lymphocyte responses to RSV antigens in humans [24] . In the present study, we have compared RSV-induced expression of several proinflammatory, immunoregulatory, and chemotactic cytokines in aged and young RSV-infected cotton rats. The majority of cytokines analyzed here, including IFN-g, IL-10, IL-6, and GRO, peaked in the lungs of young cotton rats on day 4 after infection, but, in the lungs of aged cotton rats, these cytokines did not reach maximum expression level until day 6 after infection.
The shift in the peak cytokine expression patterns between young and aged cotton rats may reflect age-dependent differences in the dynamics of pulmonary RSV replication. It has been shown that, whereas RSV replication in the lungs of young cotton rats reaches its peak on day 4 after infection and declines to undetectable level by day 6, virus persists in the lungs of aged cotton rats beyond day 6 and is not cleared until day 8 after infection ( [26] ; the present study). The cytokine expression shifting might reflect either the direct influence that viral replication has on certain cytokines' expression, thus reflecting cytopathic effect of RSV, or it may indicate an imbalance of regulatory mechanisms associated with age, thus representing an immunomodulatory component of RSV pathogenesis. IL-6 appears to be an example of a cytokine in the first category. A strong link between IL-6 mRNA expression and viral replication is highlighted by the fact that levels of this cytokine are decreased by antiviral compound but not by anti-inflammatory treatment, much the same as the pulmonary RSV replication. Dependence of IL-6 expression in vivo on pulmonary RSV replication was also noted in earlier work from our laboratory [34] . The cytokines IFN-g, IL-10, and MCP-1 appear to be linked more to the immunomodulatory component of RSV disease. Expression of these cytokines was affected more by anti-inflammatory than by antiviral treatment and paralleled changes in pulmonary inflammation more closely than those in viral replication.
The delay in the RSV-induced cytokine expression noted in aged cotton rats might be associated with an age-related defect in innate immune response. Functions of macrophages, NK cells, and neutrophils were reported to decline with age [42] . For example, expression of macrophage Toll-like receptors (TLRs), which are responsible for recognition of microbial pathogens and for linking innate and adaptive immune systems, is reduced with age [43] . TLR4 was recently shown to be involved in regulating innate immune response to RSV [44] [45] [46] . Reduced responsiveness of macrophages in the aged cotton rats associated with decreased expression of TLR4 might result in delayed production of cytokines, such as IL-10 and MCP-1 during RSV infection. Similarly, age-related decline in function of NK cells, an important source of IFN-g, might be associated with the shifting expression of IFN-g in the aged RSV-infected cotton rats. Age-related reduction in the killing potential of neutrophils and their excessive death due to apoptosis [42] might be the reasons for increased production of GRO by aged cotton rats, in an attempt to compensate for neutrophil dysfunction through increased chemotaxis.
Some studies suggest that cytokine production in elderly individuals might be associated with a disregulation in the Th1/ Th2-type responses characterized by reduced production of Th1-type cytokines and elevated production of Th2-type cytokines [20] . During the acute pulmonary response to RSV infection in cotton rats we have not observed an elevation in the IL-4 mRNA or a decrease in the IFN-g mRNA associated with the age of infected cotton rats, thus arguing against a skewed Th1/Th2-type cytokine response. We did observe the age-dependent shift in the pattern of IFN-g expression, suggesting that, whereas the basic mechanisms controlling RSV infection are conserved independently of age, the dynamics of activation and maintenance of such responses might be skewed.
Overall, this work establishes a ground for a side-by-side comparison of pulmonary cytokine expression between RSVinfected aged and young cotton rats, revealing a shifting agedependent establishment of proinflammatory and immunomodulatory environment in the lungs. Although limited in representing human RSV disease in aged groups, in which multiple reinfections occur during the life span, our findings suggest that the differences in cytokine expression found between the young and elderly individuals with RSV infection might be related to differential kinetics in viral replication. The present study demonstrates the effectiveness of antiviral and antiinflammatory treatment of RSV disease in aged cotton rats and highlights the importance of virus-mediated and host-mediated components of RSV pathogenesis. The shift in cytokine expression accompanying skewing of viral replication and certain chemokine imbalances (e.g., GRO) detected in aged cotton rats suggests that there are age-related structural/functional changes in the lungs.
